Janet E. Pope, Boulos Haraoui, Emmanouil Rampakakis, Eliofotisti Psaradellis, Carter Thorne, John S. Sampalis and on behalf of the Optimization of Adalimumab Trial Investigators Treating to a Target in Established Active Rheumatoid Arthritis Patients Receiving a Tumor Necrosis Factor Inhibitor: Results From a Real-World Cluster-Randomized Adalimumab Trial Arthritis Care & Research 65
Article first published online: 26 AUG 2013 | DOI: 10.1002/acr.22010
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.